Literature DB >> 19261797

"Mycobacterium tilburgii," a newly described, uncultivated opportunistic pathogen.

Tara N Palmore1, Yvonne R Shea, Patricia S Conville, Frank G Witebsky, Victoria L Anderson, Irene P Rupp Hodge, Steven M Holland.   

Abstract

Molecular methods are increasingly used to identify pathogens that are difficult to cultivate. We report a case of disseminated infection with "Mycobacterium tilburgii," a proposed species that has never been cultivated. The case illustrates the diagnostic utility of sequence analysis of the 16S rRNA gene directly from clinical specimens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19261797      PMCID: PMC2681830          DOI: 10.1128/JCM.02385-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Detection, identification, and treatment of a novel, non-cultivable Mycobacterium species in an HIV patient.

Authors:  E Richter; S Rüsch-Gerdes; S Niemann; A Stoehr; A Plettenberg
Journal:  AIDS       Date:  2000-07-28       Impact factor: 4.177

2.  A high proportion of novel mycobacteria species identified by 16S rDNA analysis among slowly growing AccuProbe-negative strains in a clinical setting.

Authors:  Ryan J Pauls; Christine Y Turenne; Joyce N Wolfe; Amin Kabani
Journal:  Am J Clin Pathol       Date:  2003-10       Impact factor: 2.493

3.  Identification of bacteria recovered from clinical specimens by 16S rRNA gene sequencing.

Authors:  P Kiratisin; L Li; P R Murray; S H Fischer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-01       Impact factor: 3.267

Review 4.  Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases.

Authors:  Jill E Clarridge
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Identification of nocardia species by restriction endonuclease analysis of an amplified portion of the 16S rRNA gene.

Authors:  P S Conville; S H Fischer; C P Cartwright; F G Witebsky
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Localized pulmonary infection associated with Mycobacterium tilburgii in an HIV-infected patient.

Authors:  M Kolditz; M Halank; P Spornraft-Ragaller; H Schmidt; G Höffken
Journal:  Infection       Date:  2005-08       Impact factor: 3.553

7.  Nocardia veterana as a pathogen in North American patients.

Authors:  Patricia S Conville; June M Brown; Arnold G Steigerwalt; Judy W Lee; Dorothy E Byrer; Victoria L Anderson; Susan E Dorman; Steven M Holland; Barbara Cahill; Karen C Carroll; Frank G Witebsky
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

8.  "Mycobacterium tilburgii" infections.

Authors:  Dirk Wagner; Margreet Vos; Anton G M Buiting; Annerose Serr; Anneke M C Bergmans; Winfried Kern; Leo M Schouls
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

  8 in total
  5 in total

1.  IL-12Rβ1 deficiency and disseminated Mycobacterium tilburgii disease.

Authors:  Kinda Schepers; Liliane Schandené; Jacinta Bustamante; Jean-Paul Van Vooren; Maylis de Suremain; Jean-Laurent Casanova; Jean Cyr Yombi; Frédérique Jacobs; Françoise Mascart; Jean-Christophe Goffard
Journal:  J Clin Immunol       Date:  2013-10-10       Impact factor: 8.317

2.  "Mycobacterium tilburgii" infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis.

Authors:  Nico G Hartwig; Adilia Warris; Esther van de Vosse; Adri G M van der Zanden; Tanja Schülin-Casonato; Jakko van Ingen; Rob van Hest
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

3.  Disseminated infection with Mycobacterium tilburgii in a male immunocompromised patient.

Authors:  Sarah Temmerman; Linos Vandekerckhove; Erica Sermijn; Dirk Vogelaers; Geert Claeys; Mario Vaneechoutte; Piet Cools; Steven Callens
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

4.  Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection.

Authors:  Jan Heyckendorf; Sven Philip Aries; Ulf Greinert; Elvira Richter; Holger Schultz; Christoph Lange
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

Review 5.  Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases.

Authors:  Surendra K Sharma; Vishwanath Upadhyay
Journal:  Indian J Med Res       Date:  2020-09       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.